Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is microcystic adnexal carcinoma?
Microcystic adnexal carcinoma (MAC) is a rare skin cancer that arises from the sweat-gland and hair-follicle structures (the skin's adnexa). It most often appears on the face — especially the upper lip, cheek, and around the eyes — as a slow-growing, firm, flesh-colored or yellowish patch or plaque that can look deceptively bland, like a scar or a small area of thickened skin. Because it grows so quietly and resembles harmless conditions, it is frequently present for years before it is diagnosed. The defining behavior of MAC is the key to understanding its treatment: it is locally aggressive but almost never spreads to distant parts of the body. It sends out deep, finger-like extensions that burrow far beneath and beyond what can be seen or felt, and it has a strong tendency to grow along nerves (perineural invasion), which can cause numbness, tingling, or — when nerves of the face are involved — muscle weakness. This hidden, deep, and nerve-following growth is why MAC so often comes back after an incomplete removal and why simply cutting out the visible lesion is not enough. Because distant spread is so rare, the entire treatment strategy centers on completely clearing the tumor locally. That usually means margin-controlled surgery, in which the edges of the removed tissue are checked carefully under the microscope (often Mohs surgery) to trace and remove the hidden extensions while sparing as much of the face as possible. Radiation plays an important supporting role for tumors that cannot be fully removed, that have positive margins, or that show extensive nerve involvement.
The main types
Doctors group microcystic adnexal carcinoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Classic microcystic adnexal carcinoma | The usual slow-growing facial form — a firm, scar-like plaque that is locally invasive and nerve-seeking but does not spread to distant organs; treated by complete removal. |
| With extensive perineural invasion | A tumor that has grown along nerves, sometimes over long distances; harder to clear surgically and often treated with added radiation. |
| Recurrent microcystic adnexal carcinoma | A tumor that has come back after prior treatment, usually because deep or nerve-following extensions were left behind; managed with wider margin-controlled surgery and frequently radiation. |
Staging, in plain terms
Microcystic adnexal carcinoma can technically be described with the TNM staging used for skin cancers, which considers the size and depth of the tumor (T), whether it has reached lymph nodes (N), and whether it has spread to distant organs (M). In practice, however, formal staging plays a smaller role than it does for most cancers, because MAC almost never spreads to nodes or beyond. The questions that actually drive treatment are local ones: how deep and how far the tumor and its hidden, root-like extensions reach, and whether they involve nerves. Two features especially shape care. First is depth and subclinical extension — MAC routinely reaches far deeper and wider than it looks, which is why margin-controlled surgery that traces the edges microscopically is so important and why the true extent only becomes clear during that process. Second is perineural invasion, the tumor's habit of creeping along nerves; when nerves are extensively involved, the risk of leaving disease behind rises, and radiation is often added. Because nodal and distant spread are so unusual, imaging of the rest of the body and lymph node procedures are generally unnecessary for typical MAC, reserved for the rare atypical case. In short, MAC is managed less by a stage number and more by completely clearing the deep, nerve-following tumor locally, with radiation supporting surgery when complete removal is uncertain.
| Skin carcinoma TNM framework, but managed mainly by complete local removal because distant spread is very rare | What it generally means |
|---|---|
| Localized, resectable | A tumor confined to the skin and underlying tissue that can be completely removed with margin control; surgery is usually curative. |
| Locally advanced or deeply invasive | A larger or deeper tumor, or one in a location where complete removal is difficult (such as around the eye or central face); treated with margin-controlled surgery plus radiation. |
| Extensive perineural involvement | A tumor that has grown along nerves; radiation is commonly added to surgery to treat disease that follows nerves beyond what surgery can reach. |
| Recurrent | A tumor that has returned after prior treatment; managed with wider re-excision and radiation, with attention to the nerves and deep tissue where it tends to persist. |
The standard of care
Microcystic Adnexal Carcinoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Mohs / margin-controlled surgery
The main curative treatment — removing the tumor while checking the edges microscopically (often in stages) to trace and clear its deep, hidden extensions while sparing as much of the face as possible.
Wide local excision with margin assessment
An alternative when Mohs isn't available, removing the tumor with a generous margin and careful pathology review of the edges.
Radiation therapy
Used after surgery when margins are close or involved and further surgery isn't feasible, for extensive nerve involvement, or as the main treatment for tumors that can't be removed.
Long-term follow-up
Because MAC can recur years later, regular skin and nerve exams of the treated area are important to catch any return early.
How radiation treatment works
Radiation therapy treats microcystic adnexal carcinoma by delivering focused energy that damages the DNA inside the tumor cells so they lose the ability to grow and divide. The role of radiation follows directly from how this cancer behaves. MAC's defining traits are that it burrows far deeper and wider than it appears and that it tends to grow along nerves — and both of these make complete surgical removal challenging and make radiation, which can treat a broad area including microscopic and nerve-following disease, a valuable partner to surgery. The cornerstone of cure is margin-controlled surgery (often Mohs), which traces and removes the hidden extensions. Radiation is added in the situations where clearing the tumor surgically is uncertain: when the edges of the removed tissue come back close to or involved by cancer and further surgery isn't practical, radiation to the surgical area treats the microscopic cells left behind; and when the tumor has grown extensively along nerves, the radiation field can be extended along those nerve pathways toward their roots to treat disease that surgery cannot reach. Radiation can also be the primary treatment for a tumor that cannot be removed because of its size or location on the face. Because MAC almost never spreads to distant organs, the goal of radiation is local control — eradicating the disease in and around the original site and along the involved nerves — rather than treating the whole body. Modern techniques such as intensity-modulated radiation shape the dose tightly around the target, which is essential on the face, where the tumor often sits near the eye and important nerves. Used thoughtfully alongside margin-controlled surgery, radiation makes durable local control achievable even for deep, nerve-involving, or hard-to-remove tumors.
The main ways radiation is delivered for microcystic adnexal carcinoma:
Postoperative (adjuvant) radiation
Radiation to the surgical area after removal, used when margins are close or positive and re-excision isn't practical, or when the tumor has grown along nerves — it treats microscopic disease and lowers the chance of recurrence.
Definitive radiation
For a tumor that cannot be removed because of size or location, focused external-beam radiation can serve as the primary treatment to control the disease.
Nerve-pathway (perineural) coverage
When the tumor follows nerves, the radiation field is extended along the involved nerve pathways toward their roots to treat disease that surgery cannot reach.
Intensity-modulated radiation (IMRT)
Shaping the beams tightly around the target on the face protects the eye, nerves, and other delicate structures while delivering a full dose to the tumor and its nerve pathways.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Mohs surgery offers the best local control: Series comparing treatments for microcystic adnexal carcinoma show that Mohs (margin-controlled) surgery achieves lower recurrence than standard excision, reflecting how completely tracing the tumor's deep, hidden extensions is the key to cure.[1]
MAC Mohs surgery outcome studies
Radiation helps when margins or nerves are involved: Studies report that adding radiation after surgery for MAC with positive margins or extensive perineural invasion, or using it for unresectable tumors, improves local control, supporting its role when complete surgical clearance is uncertain.[2]
MAC adjuvant radiotherapy series
Distant spread is very rare: Long-term data confirm that microcystic adnexal carcinoma almost never metastasizes to lymph nodes or distant organs, which is why treatment focuses on thorough local control rather than systemic therapy or routine staging scans.[3]
MAC natural history and metastasis data
Common questions
Is microcystic adnexal carcinoma dangerous? It is a true cancer, but a relatively favorable one because it almost never spreads to other parts of the body. Its challenge is local: it grows deeper and wider than it looks and tends to follow nerves, so it can come back where it started — and damage nearby structures on the face — if it isn't completely removed. With thorough margin-controlled surgery, and radiation when needed, most people are cured.
Why is special surgery (Mohs) often recommended? Because MAC sends out deep, hidden extensions and creeps along nerves well beyond its visible edge, simply cutting out the visible lesion frequently leaves disease behind. Margin-controlled surgery such as Mohs checks the edges of the removed tissue under the microscope, in stages, to trace and clear those hidden extensions — which both improves the cure rate and spares as much healthy facial tissue as possible.
When is radiation used? Surgery is the main treatment, but radiation is added when the surgical edges come back close or involved and further surgery isn't practical, when the tumor has grown extensively along nerves, or as the primary treatment when a tumor can't be removed because of its size or location. The radiation field can be extended along involved nerve pathways to treat disease that surgery cannot reach.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.